Your browser doesn't support javascript.
loading
Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.
Pelliccia, Francesco; Alfieri, Ottavio; Calabrò, Paolo; Cecchi, Franco; Ferrazzi, Paolo; Gragnano, Felice; Kaski, Juan Pablo; Limongelli, Giuseppe; Maron, Martin; Rapezzi, Claudio; Seggewiss, Hubert; Yacoub, Magdi H; Olivotto, Iacopo.
Afiliação
  • Pelliccia F; Department of Cardiovascular Sciences, University Sapienza of Rome, Rome, Italy. Electronic address: f.pelliccia@mclink.it.
  • Alfieri O; Department of Cardiovascular and Thoracic Surgery, San Raffaele University Hospital, Milan, Italy.
  • Calabrò P; Division of Cardiology, A.O.R.N. 'Sant'Anna e San Sebastiano', Caserta, Italy; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Cecchi F; IRCCS Istituto Auxologico Italiano, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.
  • Ferrazzi P; Hypertrophic Cardiomyopathy Center, Policlinico di Monza, Monza, Italy.
  • Gragnano F; Division of Cardiology, A.O.R.N. 'Sant'Anna e San Sebastiano', Caserta, Italy; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Kaski JP; Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital, University College London Institute of Cardiovascular Science, London, UK.
  • Limongelli G; Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy; Institute of Cardiovascular Sciences, University College of London, St. Bartholomew's Hospital, London, UK.
  • Maron M; Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA, USA.
  • Rapezzi C; Cardiology, University of Ferrara & Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.
  • Seggewiss H; Klinikum Würzburg Mitte - Standort Juliusspital, Würzburg, Germany.
  • Yacoub MH; Heart Science Centre, National Heart and Lung Institute, Imperial College London, London, UK.
  • Olivotto I; Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Int J Cardiol ; 304: 86-92, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31983465
ABSTRACT
Patients with hypertrophic cardiomyopathy (HCM) exhibit a variable phenotype with ventricular hypertrophy as the cardinal manifestation and left ventricular (LV) outflow tract obstruction (LVOTO) as a key pathophysiologic determinant. Patients with severe LVOTO usually present with exertional dyspnea, exertional syncope, and heart failure symptoms, while successful relief of LVOTO by pharmacological or invasive interventions leads to a dramatic improvement in clinical status. Proper management of obstructive HCM remains challenging and poses numerous clinical dilemmas. Since the development of surgical myectomy over half a century ago, progress in the management of LVOTO in HCM has paralleled technological advances in genetic testing, cardiac imaging, arrhythmic prophylaxis, cardiac surgery and interventional cardiology. These changes have been incorporated in dedicated scientific guidelines on both sides of the Atlantic. However, either the 2011 American guidelines or the 2014 European guidelines remain largely based on expert consensus for lack of recommendations with level of evidence A regarding any of the treatment options commonly employed in HCM. Consequently, management of obstructive HCM patients remains largely subjective and dependent on clinical judgment, local expertise, and patient preference. Following the trend that has emerged for other cardiac diseases amenable to invasive interventions, adequate evaluation and management of obstruction in HCM today requires a multidisciplinary team capable of optimizing referral, choosing the best available options, minimizing complications and ensuring state-of-the-art results. The concept of an HCM Heart Team is coming of age. This review aims to provide an update of available pharmacologic and invasive options for the management of LVOTO in HCM, either in adulthood or in childhood, highlighting areas for multidisciplinary integration and future development.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Obstrução do Fluxo Ventricular Externo / Cardiopatias Congênitas / Insuficiência Cardíaca / Procedimentos Cirúrgicos Cardíacos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Obstrução do Fluxo Ventricular Externo / Cardiopatias Congênitas / Insuficiência Cardíaca / Procedimentos Cirúrgicos Cardíacos Idioma: En Ano de publicação: 2020 Tipo de documento: Article